Galera Therapeutics CEO J Sorensen's 2019 pay jumps 373% to $2.5M
Galera Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
Galera Therapeutics reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, three executives at Galera Therapeutics received on average a compensation package of $2.1M, a 349% increase compared to previous year.
Average pay of disclosed executives at Galera Therapeutics
J. Mel Sorensen, Chief Executive Officer, received $2.5M in total, which increased by 373% compared to 2018. 77% of Sorensen's compensation, or $1.9M, was in option awards. Sorensen also received $140K in non-equity incentive plan and $432K in salary.
Christopher Degnan, Chief Financial Officer, received a compensation package of $2.2M. 92% of the compensation package, or $2.1M, was in option awards.
Robert A. Beardsley, Chief Operating Officer, earned $1.7M in 2019, a 294% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2020.